Samantha Cohen, MD
- ASSISTANT PROFESSOR | Obstetrics, Gynecology and Reproductive Science
- Cancer (Oncology)
- Gynecologic Oncology
- Hospital Affiliations
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai Beth Israel
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai Morningside and Mount Sinai West
- Mount Sinai Brooklyn
Dr. Samantha Cohen is a board certified gynecologic oncologist at The Mount Sinai Hospital. She is a graduate of the Albert Einstein College of Medicine and completed both her OB/GYN residency and gynecologic oncology fellowship at Mount Sinai. As a gynecologic oncologist, Dr. Cohen specializes in the diagnosis and treatment of gynecologic malignancies, such as uterine, ovarian, and cervical cancer. Dr. Cohen also specializes in minimally invasive surgical techniques, including laparoscopic and robotic surgery, treatment of cervical dysplasia, and management of complex non-malignant gynecological conditions.
Dr. Cohen’s research activities include being a founding member of the Ovarian Cancer Translational Research Program, which was launched at Icahn School of Medicine at Mount Sinai and today is a multicenter consortium. Her research efforts have been nationally recognized, including recent publications in the peer-reviewed journals, Gynecologic Oncology and Journal of Ovarian Research. She is an active member of the Society of Gynecologic Oncology, American Society of Clinical Oncology, and the American College of Obstetricians and Gynecologists.
Dr. Cohen has been featured consistently since 2013 as a New York Magazine Best Doctor in the publication’s annual special issue highlighting clinical excellence.
Obstetrics & Gynecology
- Cervical Cancer
- Endometrial Cancer
- Lynch Syndrome
- Ovarian Cancer
- Uterine Cancer
- Vaginal Cancer
- Vulvar Cancer
MD, Albert Einstein College of Medicine
Mount Sinai School of Medicine
Fellowship, Gynecologic Oncology
Mount Sinai School of Medicine
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Cohen did not report having any of the following types of financial relationships with industry during 2020 and/or 2021: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.